ROSSI DINO A
SEC Form 4 insider trading activity
ROSSI DINO A has filed 2 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, ROSSI DINO A is listed as Director at Krystal Biotech, Inc. Inside the rolling window, ROSSI DINO A reported no open-market purchases and 2 open-market sales totaling $13.2M in KRYS. The largest disclosed transaction in the window is a sale of 25,000 KRYS shares on Aug 14, 2026, worth $8.2M.
Companies traded
Other insiders at KRYS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ROSSI DINO A made?
ROSSI DINO A has filed 2 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.
Which companies does ROSSI DINO A trade?
ROSSI DINO A has filed SEC Form 4 disclosures for 1 company, including KRYS.
When was ROSSI DINO A's most recent SEC Form 4 filing?
ROSSI DINO A's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is ROSSI DINO A's total buy and sell value in the current window?
Inside the rolling retention window, ROSSI DINO A bought $0 and sold $13.2M based on SEC Form 4 filings.
What was ROSSI DINO A's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 KRYS shares on 2026-08-14, worth $8.2M, per SEC Form 4 filings.